News Archive

This position reports to and works directly with the President & CEO and in close collaboration with the Director of Finance and Managing Director, Economic Development. The Executive Administrator also works closely with other staff members to ensure smooth operations and effective collaboration. As the representative of BioHealth Innovation, the Executive Administrator will provide administrative work in coordination with external leaders, constituents and board members.

To apply, please send a cover letter, resume, and salary requirements to jobs@biohealthinnovation.org.

As part of its ongoing efforts to accelerate patient access to safe, effective, and potentially curative gene therapies, the Alliance for Regenerative Medicine (ARM) today announced the launch of the ARM Foundation for Cell and Gene Medicine. This independent, 501(c)(3) non-profit organization is dedicated to increasing public awareness and understanding of the clinical and societal benefits of cell and gene medicine — including gene therapy, gene editing, cell therapy, tissue-engineering, and organ regeneration — and supporting its development through education and research projects.

We invite you to join us for the first event of the 2018 Inova Discovery Series: Early Stage Investing in Health Technology on Thursday, June 21, 2018, at the Inova Center for Personalized Health located at 3225 Gallows Road Fairfax, VA 22031.

Biotechnology and life sciences discoveries are deeply embedded in our DNA. MoCo is home to a thriving global hub, where life-saving innovations emerge every day. Our BioHealth clusters have more than 10,000 employees working in the private sector and an estimated 49,000 in federal government agencies along Montgomery County’s I-270 corridor, a lively and growing biohealth hotbed.

The National Institutes of Health on Monday announced a sweeping initiative to revamp the way it manages data in an effort to foster the adoption of artificial intelligence, supercomputing and other technologies poised to transform medical research.

With more than 90% of the biopharmaceutical industry made up of small, emerging companies, it is important for BIO to better understand early-stage investor and deal-making trends in order to determine where scientific or policy issues may be impacting the industry’s ability to maintain a robust pipeline of innovative medicines. The ability to access capital and form strategic alliances is vital for small therapeutic-focused companies to succeed in translating novel drug candidates into approved medical products for patients.

The conference is aimed at bringing together global companies to showcase the successes and future innovation of the innovative medicines manufacturing sector, which is already worth £30 billion to the economy.

The National Institutes of Health (NIH) invests nearly $37.3 billion annually in medical research. More than 80% of the funding is awarded through nearly 50,000 competitive grants to more than 300,000 researchers at more than 2500 universities, medical schools, and other research institutions in every U.S. state and around the world.

Renowned worldwide for its technological prowess in fields like cybersecurity, artificial intelligence, IT, and smart mobility, Israel is also continuing to gain recognition for its invaluable contributions to the worlds of biotechnology and the life sciences – technologies which help improve healthcare and quality of life for millions worldwide.

Tuesday, June 19, 2018 – 5:30 p.m. – 7:30 p.m. EST

It’s been a wonderful spring for Women In Bio in Baltimore. Local organizers have put on amazing morning meet-ups featuring outstanding women scientists-entrepreneurs and business leaders. Let’s cap off this “season” with a Capital Region chapter-wide event. At this evening mixer, we’ll get to know each other more and meet new people in the bio scene in Baltimore and beyond.